Clinical Roundup Alligator Bioscience initiates phase I study of intratumoral mitazalimab in locally advanced pancreatic cancer May 17, 2024Vol.50 No.20
Clinical Roundup Kyowa Kirin forms global collaborative with advocacy groups to address unmet needs in cutaneous T-cell lymphoma May 17, 2024Vol.50 No.20
Clinical Roundup Merck discontinues arm of phase III trial evaluating vibostolimab + pembrolizumab in adjuvant high-risk melanoma May 17, 2024Vol.50 No.20
Drugs & Targets FDA, EMA grant Orphan Drug Designation to Carthera for carboplatin with SonoCloud technology in glioma May 17, 2024Vol.50 No.20
Drugs & Targets Leal Health announces next-gen AI patient support platform to enable cancer treatment navigation May 17, 2024Vol.50 No.20
Trials & Tribulations Single-cell based precision oncology: First steps in addressing and overcoming tumor heterogeneity May 10, 2024Vol.50 No.19By Sanju Sinha and Eytan Ruppin
Guest Editorial OCE’s Project 5 in 5 seeks to inspire pragmatic innovation May 10, 2024Vol.50 No.19By Steven C. Cunningham, Donna R. Rivera, Richard Pazdur, Kelly J. Norsworthy and Jennifer Gao
Guest Editorial Voices of Black women can improve cancer outcomes May 10, 2024Vol.50 No.19By Alpa V. Patel
In Brief Norman Wolmark receives American Surgical Association Medallion for Advancement of Surgical Care May 10, 2024Vol.50 No.19
In Brief Nickolas Papadopoulos named editor-in-chief of Cancer Prevention Research May 10, 2024Vol.50 No.19
